期刊文献+

卡托普利治疗稳定劳力型心绞痛的临床效果 被引量:2

Clinical efficacy of captopril in treatment of stable exertional angina pectoris
下载PDF
导出
摘要 目的:卡托普利在治疗稳定性劳力型心绞痛在临床治疗中的效果分析。方法选取2005年3月~2012年10月来我院进行治疗的稳定性劳力型心绞痛患者共200例,年龄为53~72岁,并随机分成两组观察组与对照组,每组各100例。对照组与观察组分别采用常规的治疗方法以及在常规治疗方法的基础上施以卡托普利治疗。其中,常规的治疗方法主要是采用β-受体阻滞剂,阿司匹林,硝酸酯类以及钙拮抗剂进行治疗。对两组的治疗情况进行观察与分析。结果在经过一段时间的临床应用治疗之后,观察组与对照组的稳定性劳力性心绞痛的治疗效果有着明显的改善,但是观察组的治疗效果明显优于对照组,观察组与对照组见的心率明显不一样,观察组慢于对照组。并且在运动过程中观察组的心绞痛病症诱发时间明显长于对照组。结论卡托普利在治疗稳定劳力型心绞痛病症的过程中有着显著的疗效,具有重要的临床意义。 Objective To analyze the clinical efficacy of captopril in the treatment of stable exertional angina pectoris. Methods A total of 100 patients with stable exertional angina pectoris (mean age 53-72 years), who were treated in our hospital from March 2005 to October 2012, were selected as subjects and randomly divided into observation group and control group. The control group received conventional treatment (β-blockers, aspirin, nitrate, and calcium antagonists), while the observation group received captopril in addition to conventional treatment. The treatment outcomes of the two groups were observed and analyzed. Results After a certain course of clinical treatment, both groups showed significant improvements, but the treatment outcome was significantly better in the observation group than in the control group; the observation group had a significantly lower heart rate than the control group. In addition, the observation group had a significantly longer angina pectoris induction time during exercise compared with the control group. Conclusion Captopril has significant efficacy in the treatment of stable exertional angina pectoris and is of great clinical significance.
作者 岩温龙
出处 《心血管病防治知识(学术版)》 2014年第2期44-46,共3页 Prevention and Treatment of Cardiovascular Disease
关键词 卡托普利 稳定性 劳力型 心绞痛 Captopril Stable Exertional Angina pectoris
  • 相关文献

参考文献4

二级参考文献15

  • 1贾如意,岳文伟,孙海玲,姜婕,虞华鹏,贾银红.卡托普利对心绞痛患者流变学和心肌缺血的影响[J].心脏杂志,2004,16(4):346-348. 被引量:10
  • 2叶任高.内科学[M].5版.北京:人民卫生出版社,2006:126.
  • 3沈渔邮.精神病学[M].4版.北京:人民卫生出版社,2002:543-544.
  • 4杨德森.康复医学[M].1版.长沙:湖南师范大学出版社,1990:287-292.
  • 5周百永,王世祥.新编常用药物手册[M].3版,北京:金盾出版社,2002:105.
  • 6Phillips m I, Kagigyama S. Angiotensin Ⅱ as a pro-inflammatory mediator [J]. Curt Opin Investig Drugs, 2002, 3 (4) : 569 -577.
  • 7Vaughan DE. Angiotensin, fibrinolysis, and vascular homeostasis[J]. Am J Cardiol, 2001,87(8A) :18C -24C.
  • 8Scheldegger KJ, Butler S, Witztum JL. Angiotensin Ⅱ increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway [ J ]. J Biol chem, 1997, 272(12) : 21609 -21615.
  • 9胡勇平,熊依良.丹参酮联合氢氯吡格雷治疗心绞痛的临床观察[J].中国医药指南,2012,10(36):416-417. 被引量:6
  • 10赵文强.硝酸甘油联合丹参川芎嗪治疗心绞痛40例[J].中国药业,2013,22(4):79-80. 被引量:11

共引文献13

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部